Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 14, 2023

Transarterial Chemoembolization vs Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

International Journal of Radiation Oncology, Biology, Physics

 

Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of Radiation Oncology, Biology, Physics
Transarterial chemoembolization with drug-eluting beads vs. stereotactic body radiation therapy for hepatocellular carcinoma: Outcomes from a multicenter randomized phase II trial (The TRENDY trial): Short running title: TACE-DEB vs. SBRT for hepatocellular carcinoma
Int. J. Radiat. Oncol. Biol. Phys 2023 Apr 08;[EPub Ahead of Print], AM Romero, B van der Holt, FEJA Willemssen, PRA de Man, PBJM Heijmen, S Habraken, H Westerveld, POM van Delden, HJ Klümpen, ETTL Tjwa, PM Braam, SFM Jenniskens, PT Vanwolleghem, R Weytjens, O d'Archambeau, J de Vos-Geelen, J Buijsen, C van der Leij, W den Toom, D Sprengers, PJNM Ijzermans, A Moelker

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading